The Very Old Intensive Care Patient: A Multinational Prospective Observation Study (VIP1)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03134807 |
Recruitment Status :
Completed
First Posted : May 1, 2017
Last Update Posted : May 15, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
- The primary aim is to document the incidence and short-term outcome of the elderly ICU patient (≥ 80 years) using a multicentre, multi national approach
- The secondary aim is to investigate the properties of a simple frailty index in this cohort, and in particular if this is an instrument that can be used in resource and outcome prediction in this group
- To create hypothesis for further studies, in particular on various outcome prediction
Condition or disease | Intervention/treatment |
---|---|
Critical Illness Old Age; Debility Survival | Other: Observation prospective |
The investigators have chosen to use a prospective registration of routinely collected data in this ICU population. The study is mainly European based, but will also allow for ICUs outside Europe to participate.
20 consecutive ICU admission in patients ≥ 80 years of age will be collected OR all patients ≥ 80 years in a three months' period (whatever comes first).
Data are collected electronically through an e-CRF and with baseline documentation of the ICU. The database is located in Denmark, at the Department of Epidemiology, University of Aarhus (http://vip1study.com/) . Each ICU will only have access through the database of their own patients, and patient ID is not registered (Names, birth-date or social security numbers) so it is in that sense anonymous.
Even with de-identified data, most countries must seek necessary consent from the authorities to collect such data, and hence there will be a period between ICU recruitment (starting April 2016) and patient recruitment (October 1. 2016) to allow for this to be done prior to study start.
The goal is to recruit at least 100 ICUs which will give data from approximately 2000 elderly patients.
Study Type : | Observational |
Actual Enrollment : | 5132 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | The Very Old Intensive Care Patient: A Multinational Prospective Observation Study |
Actual Study Start Date : | November 1, 2016 |
Actual Primary Completion Date : | June 15, 2017 |
Actual Study Completion Date : | October 31, 2017 |
Group/Cohort | Intervention/treatment |
---|---|
Admission of elderly ICU patients (≥80)
All consecutibve admission in 3 month period or 20 pateints
|
Other: Observation prospective
No intervention
Other Name: Observation and registration of data |
- Survival [ Time Frame: 30 days ]ICU and 30 days
- Frailty [ Time Frame: Pre admission ]Clinical Frailty Scale

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 80 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All admissions in the group
Exclusion Criteria:
- None

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03134807
Norway | |
General ICU, KSK; Haukeland University Hospital | |
Bergen, Norway, 5021 |
Principal Investigator: | Hans Flaatten, Prof | University of bergen; ESICM |
Responsible Party: | Hans Flaatten, Professor and senior ICU consultant, University of Bergen |
ClinicalTrials.gov Identifier: | NCT03134807 |
Other Study ID Numbers: |
ESICM VIP1 |
First Posted: | May 1, 2017 Key Record Dates |
Last Update Posted: | May 15, 2018 |
Last Verified: | May 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Critical Illness Frailty Disease Attributes Pathologic Processes |